background
kidney
transplant
donor
recipi
routin
screen
viral
pathogen
use
specif
test
littl
known
unrecogn
virus
urinari
tract
potenti
result
transmiss
use
open
metagenom
approach
aim
comprehens
assess
viru
transmiss
livingdonor
kidney
transplant
method
live
kidney
donor
correspond
recipi
enrol
time
transplant
followup
studi
visit
recipi
schedul
week
year
thereaft
visit
plasma
urin
sampl
collect
transplant
recipi
evalu
sign
infect
transplantrel
complic
metagenom
analysi
sampl
enrich
virus
amplifi
anchor
random
polymeras
chain
reaction
pcr
sequenc
use
highthroughput
metagenom
sequenc
virus
detect
sequenc
confirm
use
realtim
pcr
result
analyz
total
live
kidney
donor
recipi
pair
followup
least
year
addit
virus
commonli
detect
routin
posttranspl
viru
monitor
metagenom
sequenc
detect
jc
polyomaviru
jcpyv
urin
donor
correspond
recipi
phylogenet
analysi
confirm
infect
donor
strain
case
suggest
transmiss
transplant
donor
recipi
despit
recipi
seroposit
jcpyv
time
transplant
conclus
metagenom
sequenc
identifi
frequent
transmiss
jcpyv
kidney
transplant
donor
recipi
consid
high
incid
rate
futur
studi
within
larger
cohort
need
defin
relev
jcpyv
infect
donor
virom
transplant
outcom
donorderiv
infect
solid
organ
transplant
rang
rare
common
lifethreaten
subclin
recommend
pretranspl
screen
organ
recipi
donor
latent
activ
viral
infect
issu
includ
routin
pretranspl
care
screen
aim
identifi
donor
infect
would
disqualifi
donat
requir
prophylact
strategi
recipi
common
exampl
latter
cytomegaloviru
cmv
transmiss
consid
accept
risk
prevent
strategi
place
bk
polyomaviru
bkpyv
associ
posttranspl
complic
caus
polyomavirusassoci
nephropathi
pyvan
increas
risk
allograft
failur
transplant
recipi
besid
establish
viral
infect
role
addit
pathogen
donor
virom
understudi
surpris
ampl
exampl
transmiss
pathogen
virus
albeit
commonli
rare
occur
promin
exampl
renal
transplant
west
nile
viru
lymphocyt
choriomening
viru
human
gammaherpesviru
rabi
lyssaviru
analys
virom
thu
far
focus
sole
kidney
transplant
recipi
urinari
tract
infect
kidney
transplant
recipi
bkpyv
jc
polyomaviru
jcpyv
associ
complic
occur
transplant
whether
virus
reactiv
latenc
immunosuppress
therapi
transfer
donor
recipi
resolv
studi
ident
bkpyv
genom
sequenc
donor
recipi
indic
transmiss
via
graft
grow
uncertainti
virus
need
monitor
relev
donor
signific
rare
studi
sourc
transmiss
prompt
us
conduct
prospect
systemat
character
virom
cohort
kidney
donor
correspond
recipi
particip
monitor
time
transplant
year
posttranspl
use
open
metagenom
approach
sampl
obtain
live
kidney
transplant
donor
recipi
within
viral
metagenom
studi
clinic
research
prioriti
program
viral
infecti
diseas
univers
zurich
ethic
committe
canton
zurich
approv
studi
written
inform
consent
obtain
particip
protocol
number
kekzhnr
recipi
kidney
graft
correspond
live
donor
enrol
time
transplant
kidney
graft
recipi
consecut
posttranspl
studi
visit
plan
week
year
transplant
live
kidney
donor
singl
visit
time
organ
donat
schedul
visit
plasma
urin
sampl
collect
recipi
evalu
sign
infect
present
bk
viremia
graft
function
transplantrel
complic
cohort
divid
subset
base
chronolog
order
induct
immunosuppress
therapi
administ
recipi
consist
methylprednisolon
mg
day
surgeri
either
basiliximab
mg
day
surgeri
day
antithymocyt
immunoglobulin
atg
mg
kg
bodi
weight
day
surgeri
posttranspl
day
common
regimen
mainten
immunosuppress
consist
tacrolimu
mycophenol
mofetil
prednison
kidney
transplant
recipi
receiv
pneumocysti
jirovecii
prophylaxi
trimethoprimsulfamethoxazol
mg
daili
month
posttranspl
topic
antifung
prophylaxi
amphotericin
b
pastil
mg
time
day
administ
prednison
taper
mg
daili
recipi
intermedi
highrisk
cmv
constel
atg
induct
immunosuppress
receiv
prophylaxi
valganciclovir
oral
durat
month
other
preemptiv
strategi
follow
metagenom
sequenc
data
analysi
perform
describ
previous
supplementari
method
briefli
sampl
centrifug
filter
nucleasetr
rna
dna
amplifi
use
random
revers
transcript
anchor
pcr
separ
workflow
workflow
pool
librari
construct
nexteraxt
illumina
prior
sequenc
bp
illumina
miseq
system
read
analyz
use
virmet
http
briefli
read
qualityfilt
clean
nonvir
read
align
basic
local
align
search
tool
blast
inhous
viral
databas
contain
approxim
differ
viru
sequenc
raw
sequenc
data
jcpyv
consensu
sequenc
upload
zenodo
doi
specif
pcr
bkpyv
jcpyv
torqu
teno
viru
ttv
human
pegiviru
hpgv
perform
describ
supplementari
method
supplementari
tabl
enzymelink
immunosorb
assay
assess
jcpyvimmunoglobulin
g
igg
serostatu
perform
describ
previous
jcpyvimmunoglobulin
igm
serolog
perform
igg
use
igmspecif
secondari
antibodi
cutoff
valu
normal
optic
densiti
nod
sera
dilut
igg
igm
respect
use
defin
virom
kidney
transplant
recipi
live
donor
total
kidney
transplant
pair
includ
studi
patient
kidney
transplant
preemptiv
patient
renal
replac
therapi
prior
transplant
receiv
hemodialysi
periton
dialysi
tabl
transplant
recipi
followup
data
least
year
posttranspl
avail
major
complic
symptomat
episod
occur
period
recipi
experienc
symptom
suggest
infect
fever
gastroenter
inflammatori
syndrom
supplementari
figur
time
point
studi
visit
context
routin
posttranspl
care
viral
quantit
pcr
qpcr
monitor
detect
bkpyv
cmv
blood
sampl
recipi
standard
laboratori
analys
detect
sever
case
respiratori
virus
influenza
b
viru
rhinoviru
coronaviru
throat
swab
figur
goal
obtain
comprehens
overview
viral
metagenom
kidney
donor
correspond
recipi
tabl
interestingli
case
jcpyvposit
donor
jcpyv
also
detect
urin
sampl
respect
recipi
week
year
transplant
blood
kidney
recipi
ttv
found
recipi
bkpyv
recipi
confirm
find
obtain
metagenom
sequenc
blood
urin
sampl
time
point
subset
donor
recipi
test
virusspecif
pcr
bkpyv
jcpyv
ttv
individu
patientviru
specif
pcr
system
design
hpv
suspect
case
pcr
analys
confirm
case
bkpyv
jcpyv
hpv
ttv
infect
report
metagenom
sequenc
reveal
posit
case
amongst
recipi
detect
metagenom
sequenc
addit
infect
detect
urin
bkpyv
jcpyv
supplementari
tabl
blood
bkpyv
jcpyv
supplementari
tabl
next
use
subset
investig
whether
virus
predominantli
found
metagenom
analys
subset
bkpyv
jcpyv
ttvwere
gener
preval
sequencespecif
qpcr
virus
perform
blood
urin
sampl
remain
livingdonor
kidney
transplant
pair
identifi
addit
case
jcpyvposit
donorrecipi
pair
case
jcpyv
detect
donor
bkpyv
detect
urin
recipi
supplementari
tabl
defin
whether
jcpyv
recipi
due
transmiss
donor
latent
reactiv
construct
consensu
sequenc
jcpyv
isol
donor
recipi
purpos
candid
sampl
subset
sequenc
well
supplementari
tabl
full
genom
coverag
achiev
case
except
genom
cover
supplementari
figur
phylogenet
analysi
reveal
tight
cluster
jcpyv
sequenc
donorrecipi
pair
case
figur
impli
case
jcpyv
infect
contract
donor
remain
pair
despit
lower
coverag
phylogenet
analysi
reveal
distinct
strain
infect
donor
recipi
note
recipi
alreadi
posit
jcpyv
time
transplant
figur
order
confirm
exclud
pretranspl
jcpyv
infect
perform
iggspecif
serolog
particip
time
transplant
donor
recipi
seroposit
jcpyv
correspond
seropreval
among
individu
recipi
jcpyv
transmiss
donor
igg
serolog
reveal
presenc
virusspecif
antibodi
transplant
supplementari
tabl
interest
case
recipi
seroneg
time
transplant
although
posit
jcpyv
therefor
addit
perform
igg
igm
serolog
time
point
month
day
time
point
transplant
week
year
jcpyvspecif
igm
neg
time
point
contrast
jcpyvspecif
igg
low
posit
month
day
prior
transplant
well
year
undetect
week
transplant
supplementari
tabl
shown
case
transplantationrel
immunosuppress
ttv
load
increas
kidney
transplant
recipi
transplant
viral
load
reach
highest
level
week
posttransplant
supplementari
figur
find
signific
differ
viral
load
ttv
recipi
without
cmv
bkpyv
replic
respect
hpgv
recent
report
predomin
persist
compon
blood
virom
immunosuppress
patient
transplant
metagenom
analysi
subset
recipi
pick
hpgv
test
sampl
search
hpgv
specif
pcr
subset
subset
recipi
detect
singl
case
hpgv
subset
recipi
studi
metagenom
recipi
receiv
induct
immunosuppress
treat
basiliximabmethylprednisolon
minor
atgmethylprednisolon
tabl
case
jcpyv
replic
detect
patient
receiv
induct
immunosuppress
basiliximabmethylprednisolon
recipi
wherea
none
recipi
administr
atgmethylprednisolon
test
posit
jcpyv
replic
fisher
exact
test
p
investig
whether
jcpyv
infect
influenc
renal
function
compar
estim
glomerular
filtrat
notabl
jcpyvspecif
serolog
reveal
presenc
virusspecif
antibodi
time
transplant
case
line
previou
report
seropreval
among
individu
cohort
nevertheless
prior
immun
respons
prevent
rule
transmiss
super
infect
transplant
especi
kidney
transplant
organ
jcpyv
persist
patient
jcpyv
sequenc
donor
recipi
cluster
initi
suspect
recent
infect
recipi
individu
igg
neg
time
transplant
time
jcpyv
read
could
detect
report
case
primari
jcpyv
infect
kidney
transplant
patient
surprisingli
patient
alreadi
igg
posit
transplant
well
year
thereaft
igg
level
undetect
around
time
transplant
igm
level
undetect
time
point
reason
observ
remain
unclear
transplant
recipi
receiv
immunosuppress
therapyespeci
bcelldeplet
therapyprior
transplant
could
lower
specif
igg
level
assess
time
transplant
impact
jcpyv
replic
renal
transplant
emerg
sever
studi
report
detect
viru
urin
kidney
transplant
recipi
context
immunosuppress
individu
jcpyv
associ
clinic
entiti
progress
multifoc
leukoencephalopathi
pyvan
howev
contrast
bkpyv
jcpyv
rare
observ
caus
pathogen
pyvan
differ
result
state
literatur
regard
jcpyv
viruria
impact
transplant
outcom
one
hand
jcpyv
urinari
shed
associ
reduc
creatinin
clearanc
kidney
liver
transplant
patient
might
therefor
play
role
renal
dysfunct
hand
find
jcpyv
viruria
shown
correl
favor
clinic
cours
especi
detect
earli
interestingli
cheng
et
al
report
better
graft
surviv
lower
reject
rate
kidney
recipi
jcpyv
viruria
also
studi
clinic
renal
function
impact
seen
studi
larger
number
longer
period
observ
presum
deceas
donor
kidney
transplant
relev
might
higher
literatur
suggest
frequent
donor
origin
bkpyv
viremia
kidney
transplant
consid
detect
geneticallyident
jcpyv
isol
correspond
kidney
donor
recipi
pair
result
strongli
underlin
transmiss
donor
recipi
must
consid
also
jcpyv
note
jcpyv
detect
urin
transplant
recipi
detect
deterior
renal
function
paramet
occur
suggest
asymptomat
replic
studi
need
defin
whether
jcpyv
excret
transplant
kidney
also
dissemin
replic
recipi
consid
detect
jcpyv
urin
restrict
dissemin
eg
preexist
immun
need
consid
line
previou
report
ttv
detect
frequent
donor
recipi
level
shown
increas
transplant
recipi
consist
prior
report
transplant
patient
receiv
immunosuppress
treatment
due
low
read
number
possibl
assess
whether
ttv
also
transmit
posit
donor
recipi
detect
hpv
sever
sampl
metagenom
sequenc
cohort
provid
evid
clinic
correl
hpv
infect
remain
possibl
presenc
hpv
could
either
indic
skin
flora
contamin
asymptomat
replic
hpv
type
could
determin
accur
due
low
coverag
could
find
high
preval
hpgv
predomin
persist
compon
blood
virom
immunosuppress
transplant
patient
combin
metagenom
specificpcr
analys
singl
case
hpgvposit
note
metagenom
sequenc
plasma
urin
record
bkpyv
urin
recipi
earli
time
point
week
earliest
posit
test
blood
routin
pcr
week
figur
case
bkpyv
infect
detect
blood
routin
qpcr
time
point
week
posttranspl
wherea
metagenom
sequenc
yield
bkpyv
sequenc
urin
week
posttransplant
hand
metagenom
sequenc
also
miss
virus
identifi
pcr
sever
case
show
metagenom
sequenc
still
lack
sensit
compar
specif
pcr
find
highlight
unbias
metagenom
sequenc
method
theoret
capabl
detect
viru
clinic
specimen
empow
routin
viru
diagnost
obtain
novel
insight
influenc
donor
virom
recipi
renal
transplant
conclus
viral
metagenom
sequenc
cohort
donorrecipi
renal
transplant
pair
reveal
preval
jcpyv
transmiss
kidney
transplant
donor
recipi
least
case
consid
high
preval
jcpyv
transmiss
relev
transplant
outcom
graft
loss
life
expect
recipi
need
investig
larger
cohort
supplementari
materi
avail
clinic
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
